person · Reporting owner

Fox Michael J

Disclosed activity across 3 companies

Tapewire entity: 90138
SEC CIK: 0001589232

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Cue Biopharma, Inc.CUE · Entity 6301	Director	June 05, 2024	June 07, 2024
REGIONAL HEALTH PROPERTIES, INCRHE · Entity 8343	Director	April 24, 2018	April 26, 2018

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Cue Biopharma, Inc.

Report date June 05, 2024 · Filed June 07, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.65 · Expires 2034-06-04	Direct	48,800	Reported balance After 2024-06-05 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2024-06-05 · Grant · Acquired 48,800 · Balance 48,800 F1: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2: This option was granted on June 5, 2024. The shares underlying the option are scheduled to vest over three years with one-third vesting on the one-year anniversary of the grant date and the balance vesting in eight equal quarterly installments

Filing footnotes · ownership attribution and instrument terms

F1: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy.

F2: This option was granted on June 5, 2024. The shares underlying the option are scheduled to vest over three years with one-third vesting on the one-year anniversary of the grant date and the balance vesting in eight equal quarterly installments

REGIONAL HEALTH PROPERTIES, INC

Report date April 24, 2018 · Filed April 26, 2018

Jointly reported with Park City Capital, LLC

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	185,908	Reported balance After 2018-04-24 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2018-04-24 · Grant · Acquired 125,166 · Balance 185,908 F1: Restricted stock granted pursuant to the 2011 Stock Incentive Plan and in respect of 2018 compensation. F2: The shares of restricted stock will vest over a three-year period on the following schedule: (1) 41,722 shares on January 1, 2019; (2) 41,722 shares on January 1, 2020; and (3) 41,722 shares on January 1, 2021.
Common StockSEC Table I · non-derivative	IndirectBy Park City Capital, LLC	750,000	Reported balance Holding disclosure · report date 2018-04-24 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 750,000 F3: As the managing member of Park City Capital, LLC, Mr. Fox may be deemed to have beneficial ownership of the shares held by Park City Capital Offshore Master, Ltd. and Park City Special Opportunity Fund, LP, with respect to which Park City Capital, LLC, the investment manager to the funds, may be deemed to have beneficial ownership. F4: Does not include warrants.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock granted pursuant to the 2011 Stock Incentive Plan and in respect of 2018 compensation.

F2: The shares of restricted stock will vest over a three-year period on the following schedule: (1) 41,722 shares on January 1, 2019; (2) 41,722 shares on January 1, 2020; and (3) 41,722 shares on January 1, 2021.

F3: As the managing member of Park City Capital, LLC, Mr. Fox may be deemed to have beneficial ownership of the shares held by Park City Capital Offshore Master, Ltd. and Park City Special Opportunity Fund, LP, with respect to which Park City Capital, LLC, the investment manager to the funds, may be deemed to have beneficial ownership.

F4: Does not include warrants.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Resonant Inc

Report date March 28, 2022 · Filed March 28, 2022

Section 16 reporting ended · disclosed 2022-03-28. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2022-03-28 transaction · row 1 1 source row Row 1 · 2022-03-28 · Other · Disposed 121,168 · Balance 0
Common StockSEC Table I · non-derivative	IndirectBy Park City Capital Offshore Master, Ltd.	Reported balance After 2022-03-28 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2022-03-28 · Other · Disposed 2,000,000 · Balance 0
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-03-28 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2022-03-28 · Disposition to issuer · Disposed 65,000 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F2: In connection with the Agreement and Plan of Merger, dated February 14, 2022, by and among Murata Electronics North America, Inc., PJ Cosmos Acquisition Company, Inc. and Resonant Inc. (the "Merger Agreement"), these restricted stock units, which provided for vesting of 50% of the shares on each of May 10, 2022 and May 10, 2023, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of the holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-03-28 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2022-03-28 · Disposition to issuer · Disposed 16,949 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F3: In connection with the Merger Agreement, these restricted stock units, which provided for vesting of the shares on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 9, 2022, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of the holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-03-28 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2022-03-28 · Disposition to issuer · Disposed 26,385 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F4: In connection with the Merger Agreement, these restricted stock units, which provided for vesting of 50% of the shares on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 8, 2022, and 50% of the shares on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 8, 2023, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of the holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock.

F2: In connection with the Agreement and Plan of Merger, dated February 14, 2022, by and among Murata Electronics North America, Inc., PJ Cosmos Acquisition Company, Inc. and Resonant Inc. (the "Merger Agreement"), these restricted stock units, which provided for vesting of 50% of the shares on each of May 10, 2022 and May 10, 2023, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of the holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash.

F3: In connection with the Merger Agreement, these restricted stock units, which provided for vesting of the shares on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 9, 2022, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of the holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash.

F4: In connection with the Merger Agreement, these restricted stock units, which provided for vesting of 50% of the shares on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 8, 2022, and 50% of the shares on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 8, 2023, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of the holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 05, 2024 Filed Jun 7, 2024 16:00 UTC	Cue Biopharma, Inc. CUE · Entity 6301	GrantStock Option (right to buy) · Derivative	48,800	$0.00 Strike: $1.65	$0.00	Disclosure SEC source: 0000950170-24-070563 · ownership.xml · derivative · entry 1 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,800 Underlying: Common Stock · 48,800 shares Expires 2034-06-04 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on June 5, 2024. The shares underlying the option are scheduled to vest over three years with one-third vesting on the one-year anniversary of the grant date and the balance vesting in eight equal quarterly installments Read SEC document
March 28, 2022 Filed Mar 28, 2022 11:12 UTC	Resonant Inc RESN · Entity 128713	Disposition to issuerRestricted Stock Units · Derivative	26,385	$4.50	$118,732.50	Disclosure SEC source: 0001104659-22-038525 · tm2210529-10_4seq1.xml · derivative · entry 5 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,385 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F4 · derivative.exercise_date: In connection with the Merger Agreement, these restricted stock units, which provided for vesting of 50% of the shares on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 8, 2022, and 50% of the shares on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 8, 2023, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of the holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash. F4 · derivative.expiration_date: In connection with the Merger Agreement, these restricted stock units, which provided for vesting of 50% of the shares on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 8, 2022, and 50% of the shares on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 8, 2023, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of the holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash. Read SEC document
March 28, 2022 Filed Mar 28, 2022 11:12 UTC	Resonant Inc RESN · Entity 128713	Disposition to issuerRestricted Stock Units · Derivative	16,949	$4.50	$76,270.50	Disclosure SEC source: 0001104659-22-038525 · tm2210529-10_4seq1.xml · derivative · entry 4 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,949 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F3 · derivative.exercise_date: In connection with the Merger Agreement, these restricted stock units, which provided for vesting of the shares on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 9, 2022, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of the holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash. F3 · derivative.expiration_date: In connection with the Merger Agreement, these restricted stock units, which provided for vesting of the shares on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 9, 2022, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of the holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash. Read SEC document
March 28, 2022 Filed Mar 28, 2022 11:12 UTC	Resonant Inc RESN · Entity 128713	Disposition to issuerRestricted Stock Units · Derivative	65,000	$4.50	$292,500.00	Disclosure SEC source: 0001104659-22-038525 · tm2210529-10_4seq1.xml · derivative · entry 3 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 65,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F2 · derivative.exercise_date: In connection with the Agreement and Plan of Merger, dated February 14, 2022, by and among Murata Electronics North America, Inc., PJ Cosmos Acquisition Company, Inc. and Resonant Inc. (the "Merger Agreement"), these restricted stock units, which provided for vesting of 50% of the shares on each of May 10, 2022 and May 10, 2023, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of the holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash. F2 · derivative.expiration_date: In connection with the Agreement and Plan of Merger, dated February 14, 2022, by and among Murata Electronics North America, Inc., PJ Cosmos Acquisition Company, Inc. and Resonant Inc. (the "Merger Agreement"), these restricted stock units, which provided for vesting of 50% of the shares on each of May 10, 2022 and May 10, 2023, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of the holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash. Read SEC document
March 28, 2022 Filed Mar 28, 2022 11:12 UTC	Resonant Inc RESN · Entity 128713	OtherCommon Stock	2,000,000	$4.50	$9,000,000.00	Disclosure SEC source: 0001104659-22-038525 · tm2210529-10_4seq1.xml · nonDerivative · entry 2 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Park City Capital Offshore Master, Ltd. Disclosed balance after: 0 Read SEC document
March 28, 2022 Filed Mar 28, 2022 11:12 UTC	Resonant Inc RESN · Entity 128713	OtherCommon Stock	121,168	$4.50	$545,256.00	Disclosure SEC source: 0001104659-22-038525 · tm2210529-10_4seq1.xml · nonDerivative · entry 1 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document
June 08, 2021 Filed Jun 9, 2021 20:54 UTC	Resonant Inc RESN · Entity 128713	GrantRestricted Stock Units · Derivative	26,385	$0.00	$0.00	Disclosure SEC source: 0001104659-21-079004 · tm2119308-4_4seq1.xml · derivative · entry 6 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,385 Underlying: Common Stock · 26,385 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F4 · derivative.exercise_date: 13,193 shares shall vest on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 8, 2022, and 13,192 shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 8, 2023. F4 · derivative.expiration_date: 13,193 shares shall vest on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 8, 2022, and 13,192 shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 8, 2023. Read SEC document
June 07, 2021 Filed Jun 9, 2021 20:54 UTC	Resonant Inc RESN · Entity 128713	Exercise / conversionRestricted Stock Units · Derivative	16,949	$0.00	$0.00	Disclosure SEC source: 0001104659-21-079004 · tm2119308-4_4seq1.xml · derivative · entry 5 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,949 Underlying: Common Stock · 16,949 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F3 · derivative.exercise_date: 50% of the shares vested on June 7, 2021, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 9, 2022. F3 · derivative.expiration_date: 50% of the shares vested on June 7, 2021, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 9, 2022. Read SEC document
June 07, 2021 Filed Jun 9, 2021 20:54 UTC	Resonant Inc RESN · Entity 128713	Exercise / conversionRestricted Stock Units · Derivative	18,315	$0.00	$0.00	Disclosure SEC source: 0001104659-21-079004 · tm2119308-4_4seq1.xml · derivative · entry 4 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,315 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F2 · derivative.exercise_date: 50% of the shares vested on June 8, 2020, and 50% of the shares vested on June 7, 2021. F2 · derivative.expiration_date: 50% of the shares vested on June 8, 2020, and 50% of the shares vested on June 7, 2021. Read SEC document
June 07, 2021 Filed Jun 9, 2021 20:54 UTC	Resonant Inc RESN · Entity 128713	Exercise / conversionCommon Stock	16,949	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-21-079004 · tm2119308-4_4seq1.xml · nonDerivative · entry 2 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,168 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. Read SEC document
June 07, 2021 Filed Jun 9, 2021 20:54 UTC	Resonant Inc RESN · Entity 128713	Exercise / conversionCommon Stock	18,315	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-21-079004 · tm2119308-4_4seq1.xml · nonDerivative · entry 1 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. Read SEC document
May 10, 2021 Filed May 12, 2021 21:15 UTC	Resonant Inc RESN · Entity 128713	Exercise / conversionRestricted Stock Units · Derivative	65,000	$0.00	$0.00	Disclosure SEC source: 0001104659-21-065339 · tm2116209-4_4seq1.xml · derivative · entry 1 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F2 · derivative.exercise_date: 50% of the shares shall vest on May 10, 2022, and 50% of the shares shall vest on May 10, 2023. F2 · derivative.expiration_date: 50% of the shares shall vest on May 10, 2022, and 50% of the shares shall vest on May 10, 2023. Read SEC document
June 09, 2020 Filed Jun 10, 2020 20:02 UTC	Resonant Inc RESN · Entity 128713	GrantRestricted Stock Units · Derivative	33,898	$0.00	$0.00	Disclosure SEC source: 0001104659-20-072144 · a4.xml · derivative · entry 6 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,898 Underlying: Common Stock · 33,898 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F4 · derivative.exercise_date: 50% of the shares shall vest on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 9, 2021, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 9, 2022. F4 · derivative.expiration_date: 50% of the shares shall vest on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 9, 2021, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 9, 2022. Read SEC document
June 08, 2020 Filed Jun 10, 2020 20:02 UTC	Resonant Inc RESN · Entity 128713	Exercise / conversionRestricted Stock Units · Derivative	18,315	$0.00	$0.00	Disclosure SEC source: 0001104659-20-072144 · a4.xml · derivative · entry 5 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,315 Underlying: Common Stock · 18,315 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F3 · derivative.exercise_date: 50% of the shares vested on June 8, 2020, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 11, 2021. F3 · derivative.expiration_date: 50% of the shares vested on June 8, 2020, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 11, 2021. Read SEC document
June 08, 2020 Filed Jun 10, 2020 20:02 UTC	Resonant Inc RESN · Entity 128713	Exercise / conversionRestricted Stock Units · Derivative	4,664	$0.00	$0.00	Disclosure SEC source: 0001104659-20-072144 · a4.xml · derivative · entry 4 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,664 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F2 · derivative.exercise_date: 50% of the shares vested on June 10, 2019, and 50% of the shares vested on June 8, 2020. F2 · derivative.expiration_date: 50% of the shares vested on June 10, 2019, and 50% of the shares vested on June 8, 2020. Read SEC document
June 08, 2020 Filed Jun 10, 2020 20:02 UTC	Resonant Inc RESN · Entity 128713	Exercise / conversionCommon Stock	18,315	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-20-072144 · a4.xml · nonDerivative · entry 2 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,904 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. Read SEC document
June 08, 2020 Filed Jun 10, 2020 20:02 UTC	Resonant Inc RESN · Entity 128713	Exercise / conversionCommon Stock	4,664	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-20-072144 · a4.xml · nonDerivative · entry 1 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,589 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. Read SEC document
February 11, 2020 Filed Feb 13, 2020 15:47 UTC	Resonant Inc RESN · Entity 128713	PurchaseCommon Stock	134,000	$1.50	$201,000.00	Disclosure SEC source: 0001104659-20-020135 · tv538194_4.xml · nonDerivative · entry 1 Fox Michael J · CIK 0001589232 · Director Park City Capital, LLC · CIK 0001573572 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Park City Capital Offshore Master, Ltd. Disclosed balance after: 2,000,000 F1 · shares: Represents shares acquired from the Issuer in a public offering at a public offering price of $1.50 per share. F2 · balance_after: Michael J. Fox is the managing member of Park City Capital, LLC, the investment adviser of the fund that directly holds the reported securities. Mr. Fox and Park City Capital, LLC may be deemed to be beneficial owners of the securities directly held by the fund. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. Read SEC document
August 09, 2019 Filed Aug 13, 2019 11:52 UTC	Resonant Inc RESN · Entity 128713	PurchaseCommon Stock	396,000	$2.53	$1,001,880.00	Disclosure SEC source: 0001144204-19-039393 · tv527514_4.xml · nonDerivative · entry 1 Fox Michael J · CIK 0001589232 · Director Park City Capital, LLC · CIK 0001573572 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Park City Capital Offshore Master, Ltd. Disclosed balance after: 1,866,000 F1 · shares: Represents shares acquired from the Issuer in a private placement at a purchase price of $2.53 per share. F2 · balance_after: Michael J. Fox is the managing member of Park City Capital, LLC, the investment adviser of the fund that directly holds the reported securities. Mr. Fox and Park City Capital, LLC may be deemed to be beneficial owners of the securities directly held by the fund. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. Read SEC document
June 11, 2019 Filed Jun 12, 2019 20:01 UTC	Resonant Inc RESN · Entity 128713	GrantRestricted Stock Units · Derivative	36,630	$0.00	$0.00	Disclosure SEC source: 0001104659-19-035144 · a4.xml · derivative · entry 4 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,630 Underlying: Common Stock · 36,630 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F3 · derivative.exercise_date: 50% of the shares shall vest on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant or (ii) June 11, 2020, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 11, 2021. F3 · derivative.expiration_date: 50% of the shares shall vest on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant or (ii) June 11, 2020, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 11, 2021. Read SEC document
June 10, 2019 Filed Jun 12, 2019 20:01 UTC	Resonant Inc RESN · Entity 128713	Exercise / conversionRestricted Stock Units · Derivative	4,664	$0.00	$0.00	Disclosure SEC source: 0001104659-19-035144 · a4.xml · derivative · entry 3 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,664 Underlying: Common Stock · 4,664 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F2 · derivative.exercise_date: 50% of the shares vested on June 10, 2019, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 12, 2020. F2 · derivative.expiration_date: 50% of the shares vested on June 10, 2019, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 12, 2020. Read SEC document
June 10, 2019 Filed Jun 12, 2019 20:01 UTC	Resonant Inc RESN · Entity 128713	Exercise / conversionCommon Stock	4,664	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-19-035144 · a4.xml · nonDerivative · entry 1 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. Read SEC document
June 06, 2019 Filed Jun 10, 2019 16:34 UTC	Resonant Inc RESN · Entity 128713	Exercise / conversionRestricted Stock Units · Derivative	5,813	$0.00	$0.00	Disclosure SEC source: 0001104659-19-034631 · a4.xml · derivative · entry 3 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F2 · derivative.exercise_date: 50% of the shares vested on June 6, 2018, and 50% of the shares vested on June 6, 2019. F2 · derivative.expiration_date: 50% of the shares vested on June 6, 2018, and 50% of the shares vested on June 6, 2019. Read SEC document
June 06, 2019 Filed Jun 10, 2019 16:34 UTC	Resonant Inc RESN · Entity 128713	Exercise / conversionCommon Stock	5,813	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-19-034631 · a4.xml · nonDerivative · entry 1 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. Read SEC document
April 05, 2019 Filed Apr 8, 2019 06:15 UTC	Resonant Inc RESN · Entity 128713	OtherCommon Stock Warrants (Right to Buy) · Derivative	335,000	$0.00 Strike: $2.86	$0.00	Disclosure SEC source: 0001144204-19-018529 · tv518334_form4.xml · derivative · entry 3 Fox Michael J · CIK 0001589232 · Director Park City Capital, LLC · CIK 0001573572 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Park City Capital Offshore Master, Ltd. Disclosed balance after: 0 Underlying: Common Stock · 335,000 shares Expires 2019-04-25 F1 · shares: On April 5, 2019, the Reporting Person exercised warrants to purchase 335,000 shares of Common Stock of the Issuer at an exercise price of $2.86 per share. Read SEC document
April 05, 2019 Filed Apr 8, 2019 06:15 UTC	Resonant Inc RESN · Entity 128713	OtherCommon Stock	335,000	$2.86	$958,100.00	Disclosure SEC source: 0001144204-19-018529 · tv518334_form4.xml · nonDerivative · entry 1 Fox Michael J · CIK 0001589232 · Director Park City Capital, LLC · CIK 0001573572 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Park City Capital Offshore Master, Ltd. Disclosed balance after: 1,470,000 F1 · shares: On April 5, 2019, the Reporting Person exercised warrants to purchase 335,000 shares of Common Stock of the Issuer at an exercise price of $2.86 per share. F2 · balance_after: Michael J. Fox is the managing member of Park City Capital, LLC, the investment adviser of the fund that directly holds the reported securities. Mr. Fox and Park City Capital, LLC may be deemed to be beneficial owners of the securities directly held by the fund. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. Read SEC document
June 15, 2018 Filed Jun 18, 2018 08:56 UTC	Resonant Inc RESN · Entity 128713	PurchaseCommon Stock	19,028	$5.62	$106,937.36	Disclosure SEC source: 0001144204-18-034510 · tv496618_form4.xml · nonDerivative · entry 2 Fox Michael J · CIK 0001589232 · Director Park City Capital, LLC · CIK 0001573572 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Park City Capital Offshore Master, Ltd. Disclosed balance after: 1,135,000 F4 · price: Includes brokerage commissions of $0.02 per share. F1 · balance_after: Does not include currently exercisable warrants to purchase 335,000 shares of Common Stock of the Issuer held by the fund. F2 · balance_after: Michael J. Fox is the managing member of Park City Capital, LLC, the investment adviser of the fund that directly holds the reported securities. Mr. Fox and Park City Capital, LLC may be deemed to be beneficial owners of the securities directly held by the fund. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. Read SEC document
June 14, 2018 Filed Jun 18, 2018 08:56 UTC	Resonant Inc RESN · Entity 128713	PurchaseCommon Stock	80,972	$5.61	$453,848.06	Disclosure SEC source: 0001144204-18-034510 · tv496618_form4.xml · nonDerivative · entry 1 Fox Michael J · CIK 0001589232 · Director Park City Capital, LLC · CIK 0001573572 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Park City Capital Offshore Master, Ltd. Disclosed balance after: 1,115,972 F4 · price: Includes brokerage commissions of $0.02 per share. F5 · price: The price reported represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.52 to $5.60. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. F1 · balance_after: Does not include currently exercisable warrants to purchase 335,000 shares of Common Stock of the Issuer held by the fund. F2 · balance_after: Michael J. Fox is the managing member of Park City Capital, LLC, the investment adviser of the fund that directly holds the reported securities. Mr. Fox and Park City Capital, LLC may be deemed to be beneficial owners of the securities directly held by the fund. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. Read SEC document
June 12, 2018 Filed Jun 14, 2018 16:41 UTC	Resonant Inc RESN · Entity 128713	GrantRestricted Stock Units · Derivative	9,328	$0.00	$0.00	Disclosure SEC source: 0001104659-18-040186 · a4.xml · derivative · entry 1 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,328 Underlying: Common Stock · 9,328 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F2 · derivative.exercise_date: 50% of the shares shall vest on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 12, 2019, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 12, 2020. F2 · derivative.expiration_date: 50% of the shares shall vest on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 12, 2019, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 12, 2020. Read SEC document
June 07, 2018 Filed Jun 8, 2018 18:19 UTC	Resonant Inc RESN · Entity 128713	Exercise / conversionRestricted Stock Units · Derivative	5,967	$0.00	$0.00	Disclosure SEC source: 0001104659-18-039254 · a4.xml · derivative · entry 5 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,967 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F3 · derivative.exercise_date: 50% of the shares vested on June 5, 2017, and 50% of the shares vested on June 7, 2018. F3 · derivative.expiration_date: 50% of the shares vested on June 5, 2017, and 50% of the shares vested on June 7, 2018. Read SEC document
June 07, 2018 Filed Jun 8, 2018 18:19 UTC	Resonant Inc RESN · Entity 128713	Exercise / conversionCommon Stock	5,967	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-18-039254 · a4.xml · nonDerivative · entry 2 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. Read SEC document
June 06, 2018 Filed Jun 8, 2018 18:19 UTC	Resonant Inc RESN · Entity 128713	Exercise / conversionRestricted Stock Units · Derivative	5,814	$0.00	$0.00	Disclosure SEC source: 0001104659-18-039254 · a4.xml · derivative · entry 4 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,813 Underlying: Common Stock · 5,814 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F2 · derivative.exercise_date: 50% of the shares vested on June 6, 2018, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 6, 2019. F2 · derivative.expiration_date: 50% of the shares vested on June 6, 2018, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 6, 2019. Read SEC document
June 06, 2018 Filed Jun 8, 2018 18:19 UTC	Resonant Inc RESN · Entity 128713	Exercise / conversionCommon Stock	5,814	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-18-039254 · a4.xml · nonDerivative · entry 1 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. Read SEC document
April 24, 2018 Filed Apr 26, 2018 13:14 UTC	REGIONAL HEALTH PROPERTIES, INC RHE · Entity 8343	GrantCommon Stock	125,166	$0.00	$0.00	Disclosure SEC source: 0001144204-18-022525 · tv492095_4.xml · nonDerivative · entry 1 Fox Michael J · CIK 0001589232 · Director Park City Capital, LLC · CIK 0001573572 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,908 F1 · shares: Restricted stock granted pursuant to the 2011 Stock Incentive Plan and in respect of 2018 compensation. F2 · shares: The shares of restricted stock will vest over a three-year period on the following schedule: (1) 41,722 shares on January 1, 2019; (2) 41,722 shares on January 1, 2020; and (3) 41,722 shares on January 1, 2021. Read SEC document
February 16, 2018 Filed Feb 16, 2018 18:57 UTC	Resonant Inc RESN · Entity 128713	Exercise / conversionRestricted Stock Units · Derivative	12,000	$0.00	$0.00	Disclosure SEC source: 0001104659-18-010444 · a4.xml · derivative · entry 3 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F2 · derivative.exercise_date: 50% of the shares vested on February 16, 2017 and 50% of the shares vested on February 16, 2018. F2 · derivative.expiration_date: 50% of the shares vested on February 16, 2017 and 50% of the shares vested on February 16, 2018. Read SEC document
February 16, 2018 Filed Feb 16, 2018 18:57 UTC	Resonant Inc RESN · Entity 128713	Exercise / conversionCommon Stock	12,000	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-18-010444 · a4.xml · nonDerivative · entry 1 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. Read SEC document
June 06, 2017 Filed Jun 7, 2017 17:10 UTC	Resonant Inc RESN · Entity 128713	GrantRestricted Stock Units · Derivative	11,574	$0.00	$0.00	Disclosure SEC source: 0001104659-17-037962 · a4.xml · derivative · entry 4 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,574 Underlying: Common Stock · 11,574 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F3 · derivative.exercise_date: 50% of the shares shall vest on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 6, 2018, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 6, 2019. F3 · derivative.expiration_date: 50% of the shares shall vest on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 6, 2018, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 6, 2019. Read SEC document
June 06, 2017 Filed Jun 29, 2017 14:18 UTC Amendment	Resonant Inc RESN · Entity 128713	GrantRestricted Stock Units · Derivative	11,627	$0.00	$0.00	Disclosure SEC source: 0001104659-17-042480 · a4a.xml · derivative · entry 4 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,627 Underlying: Common Stock · 11,627 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F4 · shares: The original filing underreported the number of Restricted Stock Units granted on June 6, 2017. F3 · derivative.exercise_date: 50% of the shares shall vest on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 6, 2018, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 6, 2019. F3 · derivative.expiration_date: 50% of the shares shall vest on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 6, 2018, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 6, 2019. F4 · derivative.underlying_shares: The original filing underreported the number of Restricted Stock Units granted on June 6, 2017. F4 · balance_after: The original filing underreported the number of Restricted Stock Units granted on June 6, 2017. Read SEC document
June 05, 2017 Filed Jun 7, 2017 17:10 UTC	Resonant Inc RESN · Entity 128713	Exercise / conversionRestricted Stock Units · Derivative	5,967	$0.00	$0.00	Disclosure SEC source: 0001104659-17-037962 · a4.xml · derivative · entry 3 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,967 Underlying: Common Stock · 5,967 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F2 · derivative.exercise_date: 50% of the shares vested on June 5, 2017, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 7, 2018. F2 · derivative.expiration_date: 50% of the shares vested on June 5, 2017, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 7, 2018. Read SEC document
June 05, 2017 Filed Jun 7, 2017 17:10 UTC	Resonant Inc RESN · Entity 128713	Exercise / conversionCommon Stock	5,967	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-17-037962 · a4.xml · nonDerivative · entry 1 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. Read SEC document
June 05, 2017 Filed Jun 29, 2017 14:18 UTC Amendment	Resonant Inc RESN · Entity 128713	Exercise / conversionRestricted Stock Units · Derivative	5,967	$0.00	$0.00	Disclosure SEC source: 0001104659-17-042480 · a4a.xml · derivative · entry 3 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,967 Underlying: Common Stock · 5,967 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F2 · derivative.exercise_date: 50% of the shares vested on June 5, 2017, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 7, 2018. F2 · derivative.expiration_date: 50% of the shares vested on June 5, 2017, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 7, 2018. Read SEC document
June 05, 2017 Filed Jun 29, 2017 14:18 UTC Amendment	Resonant Inc RESN · Entity 128713	Exercise / conversionCommon Stock	5,967	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-17-042480 · a4a.xml · nonDerivative · entry 1 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. Read SEC document
February 16, 2017 Filed Feb 17, 2017 13:51 UTC	Resonant Inc RESN · Entity 128713	Exercise / conversionRestricted Stock Units · Derivative	12,000	$0.00	$0.00	Disclosure SEC source: 0001104659-17-010155 · a4.xml · derivative · entry 3 Fox Michael J · CIK 0001589232 · Director · 10% owner Park City Capital, LLC · CIK 0001573572 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F3 · derivative.exercise_date: 50% of the shares vested on February 16, 2017 and 50% of the shares vest on February 16, 2018. F3 · derivative.expiration_date: 50% of the shares vested on February 16, 2017 and 50% of the shares vest on February 16, 2018. Read SEC document
February 16, 2017 Filed Feb 17, 2017 13:51 UTC	Resonant Inc RESN · Entity 128713	Exercise / conversionCommon Stock	12,000	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-17-010155 · a4.xml · nonDerivative · entry 1 Fox Michael J · CIK 0001589232 · Director · 10% owner Park City Capital, LLC · CIK 0001573572 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. Read SEC document
January 09, 2017 Filed Mar 23, 2017 12:08 UTC	REGIONAL HEALTH PROPERTIES, INC ADK · Entity 8343	Other10% Convertible Subordinated Notes Due April 30, 2017 · Derivative	Not disclosed	Not disclosed	$1,000,000.00	Disclosure SEC source: 0001144204-17-016158 · v462510_4.xml · derivative · entry 1 Fox Michael J · CIK 0001589232 · Director Park City Capital, LLC · CIK 0001573572 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Park City Capital, LLC Disclosed balance after: 0 Underlying: Common Stock · 235,294 shares Expires 2017-04-30 F1 · derivative.exercise_price: On January 9, 2017, the Company's cash tender offer for its outstanding 10% Convertible Subordinated Notes Due April 30, 2017 (the "Convertible Notes") at a purchase price equal to $1,000 per $1,000 principal amount of Convertible Notes purchased, plus accrued and unpaid interest on such Convertible Notes up to, but not including, the payment date, expired. The Company accepted for payment all of the Convertible Notes validly tendered. The Reporting Persons tendered all of their Convertible Notes held by Park City Capital Offshore Master, Ltd., the principal amount of which was convertible (at a conversion price equal to $4.25 per share) into 235,294 shares of the Company's common stock, to the Company. F1 · kind: On January 9, 2017, the Company's cash tender offer for its outstanding 10% Convertible Subordinated Notes Due April 30, 2017 (the "Convertible Notes") at a purchase price equal to $1,000 per $1,000 principal amount of Convertible Notes purchased, plus accrued and unpaid interest on such Convertible Notes up to, but not including, the payment date, expired. The Company accepted for payment all of the Convertible Notes validly tendered. The Reporting Persons tendered all of their Convertible Notes held by Park City Capital Offshore Master, Ltd., the principal amount of which was convertible (at a conversion price equal to $4.25 per share) into 235,294 shares of the Company's common stock, to the Company. F1 · price: On January 9, 2017, the Company's cash tender offer for its outstanding 10% Convertible Subordinated Notes Due April 30, 2017 (the "Convertible Notes") at a purchase price equal to $1,000 per $1,000 principal amount of Convertible Notes purchased, plus accrued and unpaid interest on such Convertible Notes up to, but not including, the payment date, expired. The Company accepted for payment all of the Convertible Notes validly tendered. The Reporting Persons tendered all of their Convertible Notes held by Park City Capital Offshore Master, Ltd., the principal amount of which was convertible (at a conversion price equal to $4.25 per share) into 235,294 shares of the Company's common stock, to the Company. F1 · derivative.underlying_shares: On January 9, 2017, the Company's cash tender offer for its outstanding 10% Convertible Subordinated Notes Due April 30, 2017 (the "Convertible Notes") at a purchase price equal to $1,000 per $1,000 principal amount of Convertible Notes purchased, plus accrued and unpaid interest on such Convertible Notes up to, but not including, the payment date, expired. The Company accepted for payment all of the Convertible Notes validly tendered. The Reporting Persons tendered all of their Convertible Notes held by Park City Capital Offshore Master, Ltd., the principal amount of which was convertible (at a conversion price equal to $4.25 per share) into 235,294 shares of the Company's common stock, to the Company. F2 · derivative.underlying_shares: As the managing member of Park City Capital, LLC, Mr. Fox may be deemed to have beneficial ownership of the securities held by Park City Capital Offshore Master, Ltd. and Park City Special Opportunity Fund, LP, with respect to which Park City Capital, LLC, the investment manager to the funds, may be deemed to have beneficial ownership. Read SEC document
December 16, 2016 Filed Dec 20, 2016 00:42 UTC	REGIONAL HEALTH PROPERTIES, INC ADK · Entity 8343	GrantCommon Stock	24,510	$0.00	$0.00	Disclosure SEC source: 0001144204-16-140359 · v455384_4.xml · nonDerivative · entry 1 Fox Michael J · CIK 0001589232 · Director Park City Capital, LLC · CIK 0001573572 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,742 F1 · shares: Restricted stock granted pursuant to the AdCare Health Systems, Inc.'s 2011 Stock Incentive Plan and in respect of 2017 compensation. F2 · shares: The shares of restricted stock will vest over a three-year period on the following schedule: (1) 8,170 shares on January 1, 2018; (2) 8,170 shares of January 1, 2019; and (3) 8,170 shares on January 1, 2020. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.